Detection method of flurbiprofen gel plaster related substances

The chromatographic conditions were optimized by high-performance liquid chromatography, and the problem of poor separation of impurities in flubiprofen gel paste was solved, and the detection of high sensitivity and good separation was achieved, ensuring the quality and safety of the drug.

CN119064488APending Publication Date: 2024-12-03江苏济茗医药有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410415161.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-04-08
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing flubiprofen gel paste detection method cannot effectively separate unknown impurities and known impurities, and the sensitivity and peak shape are not good enough, which affects drug quality control and safety.

Method used

High performance liquid chromatography is used to improve the resolution and peak pattern between impurities and main peaks by optimizing chromatographic conditions, including the use of octadecylsilane bonded silica gel columns, gradient elution procedures and specific mobile phase combinations. Ensure the sensitivity and accuracy of the detection.

Benefits of technology

It realizes good separation and detection of impurities in flubiprofen gel paste, improves the sensitivity and resolution of detection, and ensures the stability and safety of drug quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119064488A_ABST
    Figure CN119064488A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of medicine detection, and relates to a flurbiprofen gel plaster related substance detection method, which comprises: carrying out quantitative detection on flurbiprofen gel plaster related substances by using high performance liquid chromatography, high performance liquid chromatography conditions are as follows: a chromatographic column uses octadecylsilane chemically bonded silica as a filler; a mobile phase A: water-glacial acetic acid (60: 5); a mobile phase B is acetonitrile; the flow rate is 1.2 ml / min; the column temperature is 30 DEG C; the detection wavelength is 254 nm; and the diluent is methanol. According to the chromatographic conditions provided by the invention, the separation degree between the impurities and the main peak is good, the peak pattern is good, the baseline fluctuation is smooth, and the peak pattern and the separation degree of the impurities are both improved compared with those of the primary chromatographic conditions.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of drug detection and relates to a method for detecting related substances of flurbiprofen gel patch. Background Art

[0002] Flurbiprofen is the precursor of flurbiprofen axetil. Under the action of carboxyl lipase, it is hydrolyzed to generate its active metabolite flurbiprofen. After flurbiprofen reaches the inflammatory site, it is taken up by prostaglandin (PG) synthesizing cells, such as macrophages and neutrophils, inhibiting the biosynthesis of PG, thereby achieving analgesic effect.

[0003] The control of related substances of products is crucial to product quality control. At present, the detection method of related substances in flurbiprofen gel patch is studied based on the Chinese Pharmacopoeia standards, the statutory standards of flurbiprofen raw materials and the manufacturer's standards. However, after the inventors reproduced the method, they found that the existing method cannot effectively separate unknown impurities from all known impurities, and there are problems such as poor sensitivity and peak shape. In order to ensure the quality of the preparation during research, production, storage, sales and use, and ensure the safety and effectiveness of the drug, it is urgent to provide a detection method with high sensitivity and good separation between impurities. Summary of the invention

[0004] In order to solve the above technical problems, the present invention provides a method for detecting related substances of flurbiprofen gel patch. The chromatographic conditions described in the present invention are compared with the standard chromatographic conditions provided in the Chinese Pharmacopoeia. Both the peak shape and separation degree of impurities are improved compared with the original chromatographic conditions.

[0005] Flurbiprofen Gel Patch may contain the following 6 known impurities in the final product:

[0006]

[0007]

[0008] The technical solution provided by the present invention is as follows:

[0009] A method for detecting related substances of flurbiprofen gel patch comprises the following steps:

[0010] High performance liquid chromatography was used to quantitatively detect the related substances in flurbiprofen gel patch;

[0011] HPLC conditions included:

[0012] Chromatographic column: Octadecylsilane bonded silica gel as filler (Thermo Acclaim120 C18 4.6mm×150mm, 5μm or chromatographic column with equivalent performance);

[0013] Mobile phase A: water-glacial acetic acid;

[0014] Mobile phase B: acetonitrile;

[0015] Flow rate: 1.2 ml / min;

[0016] Detection wavelength: 254nm;

[0017] Injection volume: 20 μl;

[0018] Diluent: methanol.

[0019] Furthermore, a gradient elution method was used, and the elution procedure was as follows:

[0020]

[0021]

[0022] Furthermore, the related substances include impurity A: 2-(4-biphenyl) propionic acid; impurity D: 4-acetyl-2-fluorobiphenyl; impurity F: 2,3-dihydroxypropyl 2-fluoro-α-methyl (1,1'-biphenyl)-4-ethyl ester.

[0023] Further, the system suitability solution and the test solution are respectively injected into a liquid chromatograph to record the chromatogram. The preparation method of the system suitability solution and the test solution is as follows:

[0024] Take the reference substance of flurbiprofen pine, impurity A, impurity D, and impurity F, add methanol to dissolve by ultrasonication, and then dilute to prepare a solution containing about 0.5 mg of flurbiprofen, 2.5 μg of impurity A, 2.5 μg of impurity D, and 2.5 μg of impurity F per 1 ml; as the system suitability solution;

[0025] Take one tablet of this product, remove the cover lining, scrape out about 3g of the paste (containing about 10mg of flurbiprofen), accurately weigh, place in a beaker, accurately add 20ml of methanol, homogenize with a homogenizer at 8000rpm for 10 minutes (be careful not to take out the paste when taking out the homogenizer), seal and ultrasonically treat for 60 minutes, add diluent, centrifuge at 8000rpm for 10 minutes, take the supernatant, filter, and take the filtrate as the test solution.

[0026] Furthermore, the test solution was diluted 100 times with a diluent to serve as a 1% self-control solution.

[0027] Furthermore, the mobile phase A is prepared by mixing water and glacial acetic acid in a volume ratio of 62:3 to 58:7, and performing ultrasonic treatment.

[0028] Furthermore, the color spectrum is recorded, and the content of individual impurities and total impurities is calculated by self-control method.

[0029] Furthermore, the calculation method of individual impurities and total impurities is:

[0030] Single impurity % = single impurity peak area / control peak area * 1%;

[0031] Total impurities % = sum of impurity peak areas / control peak area*1%.

[0032] Furthermore, the injection volume was 20 μl.

[0033] Furthermore, the column temperature was 30°C.

[0034] A method for detecting related substances of flurbiprofen gel patch comprises the following steps:

[0035] (1) Solution preparation:

[0036] Diluent: pure methanol is used;

[0037] Take flurbiprofen reference substance, impurity A, impurity D, and impurity F reference substances, add methanol to dissolve by ultrasonication, and then dilute to prepare a solution containing approximately 0.5 mg flurbiprofen, 2.5 μg impurity A, 2.5 μg impurity D, and 15 μg impurity F per 1 ml; as the system suitability solution;

[0038] Take 1 tablet of this product, remove the cover lining, scrape about 3g of the paste (containing about 10mg of flurbiprofen), accurately weigh, put it in a beaker, accurately add 20ml of methanol, use a high shear emulsifier to shear at 8000 revolutions per minute for 10 minutes (be careful not to take out the paste when taking out the high shear emulsifier), seal and ultrasonic for 60 minutes, take an appropriate amount of diluent, centrifuge at 8000 revolutions per minute for 10 minutes, take the supernatant, filter, and take the filtrate as the test solution.

[0039] (2) Chromatographic conditions:

[0040] Instrument: Agilent 1260; Detector: UV

[0041] Chromatographic column: Thermo Acclaim120 C18 4.6mm×150mm, 5μm;

[0042] Mobile phase A: water-glacial acetic acid (60:5) (mix 1800 ml of water with 150 ml of glacial acetic acid and obtain by ultrasonication);

[0043] Mobile phase B: acetonitrile;

[0044] Flow rate: 1.2 ml / min;

[0045] Column temperature: 30°C;

[0046] Detection wavelength: 254nm;

[0047] Injection volume: 20 μl;

[0048] The elution procedure is as follows:

[0049]

[0050] (3) Determination: Take 20 μl of the test solution and system suitability solution respectively and inject them into the liquid chromatograph and record the chromatogram.

[0051] Beneficial Effects

[0052] The present invention provides for the first time an optimized method for detecting related substances of flurbiprofen gel patch, and provides chromatographic conditions in which the separation between each impurity and the main peak is good and the peak shape is good, and the baseline fluctuation is gentle. Both the peak shape and the separation of the impurities are improved compared with the original chromatographic conditions. BRIEF DESCRIPTION OF THE DRAWINGS

[0053] Figure 1 Chromatogram of the test solution for detection method 1;

[0054] Figure 2 Chromatogram of the spiked solution under the detection method dichromatographic conditions (-1.2ml / min+35℃);

[0055] Figure 3 This is the chromatogram of the spiked solution under the third chromatographic condition of the detection method (-30℃+1.0ml / min);

[0056] Figure 4 This is the chromatogram of the spiked solution under the third chromatographic condition of the detection method (-30℃+1.2ml / min);

[0057] Figure 5 This is the chromatogram of the spiked solution under the third chromatographic condition of the detection method (-35℃+1.0ml / min);

[0058] Figure 6 This is the chromatogram of the high temperature sample of the test spiked solution under the chromatographic conditions of the detection method three;

[0059] Figure 7-Figure 9 These are the chromatograms of the test spiked solution and the system suitability solution under the chromatographic conditions of detection method 4. DETAILED DESCRIPTION

[0060] Example 1

[0061] Detection method 1 for related substances in flurbiprofen gel patch:

[0062] (1) Solution preparation:

[0063] Solvent (diluent): water-acetonitrile (55:45);

[0064] Test solution: Accurately weigh 20 mg of the test sample into a 10 ml volumetric flask and dilute to the mark with diluent and shake well.

[0065] (2) Chromatographic conditions:

[0066] Instrument: Agilent 1260; Detector: UV;

[0067] Chromatographic column: Thermo C18 (4.6×150 mm, 5 μm);

[0068] Mobile phase: glacial acetic acid-acetonitrile-water (5:35:60);

[0069] Flow rate: 1.0ml / min;

[0070] Column temperature: 25°C;

[0071] Detection wavelength: 254nm;

[0072] Injection volume: 20 μl;

[0073] Elution procedure: isocratic elution;

[0074] (3) Determination: Take 20 μl of blank solution and test solution respectively and inject them into liquid chromatograph. Record the chromatogram. Typical spectra are shown in Figure 1 .

[0075] (4) Results: Figure 1 It can be seen from the spectrum that the retention time of the main component is about 36 minutes, and the retention time of the double component is about 75 minutes. This method requires optimization of flow rate and column temperature to shorten the retention time of the main peak.

[0076] Example 2

[0077] Method 2 for detecting related substances in flurbiprofen gel patch:

[0078] (1) Solution preparation:

[0079] Solvent: methanol;

[0080] Impurity mother liquor: weigh 2.5 mg of each impurity into a 25 ml volumetric flask, dissolve and dilute to the scale with methanol (the sample weight of impurity A is 2.566 mg, the sample weight of impurity B is 2.644 mg, the sample weight of impurity C is 2.443 mg, the sample weight of impurity D is 2.675 mg, and the sample weight of impurity E is 2.537 mg).

[0081] System suitability solution: Weigh 10.12 mg of flurbiprofen, 100 μl of impurity A mother solution, and 40 μl of impurity B mother solution into a 20 ml volumetric flask, add methanol to dissolve and dilute to the scale.

[0082] Test solution: weigh 3 g of the paste, put it in a beaker and add 20 ml of methanol. Homogenize at 8000 rpm for 5 min, seal the beaker and ultrasonicate for 15 min at an ultrasonic power of 100 W. Add 100 μl of impurity A mother solution and 40 μl of impurity B mother solution in sequence, mix well, centrifuge at 8000 rpm for 10 min, and take the supernatant.

[0083] (2) Chromatographic conditions: Instrument: Agilent 1260; Detector: UV

[0084] Chromatographic column: Thermo C18 (4.6×150 mm, 5 μm);

[0085] Mobile phase: glacial acetic acid-acetonitrile-water (5:35:60);

[0086] Flow rate: 1.2 ml / min;

[0087] Column temperature: 35 °C;

[0088] Detection wavelength: 254nm;

[0089] Injection volume: 20 μl;

[0090] Diluent: methanol;

[0091] Elution procedure: isocratic elution

[0092] (3) Determination: Take 20 μl of the test solution and system suitability solution respectively and inject them into the liquid chromatograph. Record the chromatogram. Typical spectra are shown in Figure 2 .

[0093] (4) Results: Figure 2 As shown, the separation degree between crotamiton and impurity E is 1.20. The separation degree in the durability test does not meet the requirements, so the method is optimized to achieve better separation between crotamiton and impurity E.

[0094] Example 3

[0095] Detection method 3 for related substances in flurbiprofen gel patch:

[0096] (1) Solution preparation: the same as that in Example 2.

[0097] (2) Chromatographic conditions: Instrument: Agilent 1260; Detector: UV

[0098] Chromatographic column: Thermo C18 (4.6×150 mm, 5 μm);

[0099] Mobile phase: glacial acetic acid-acetonitrile-water (5:35:60);

[0100] Flow rate: 1.0ml / min+1.2ml / min;

[0101] Column temperature: 30℃+35℃;

[0102] Detection wavelength: 254nm;

[0103] Injection volume: 20 μl;

[0104] Elution program: isocratic elution.

[0105] (3) Determination: Inject the system suitability solution into the liquid chromatograph and record the chromatogram. Typical spectra are shown in Figure 3 .

[0106] (4) Results: Figure 3-Figure 5 As shown in the figure, under the conditions of column temperature 35℃ and flow rate 1.0ml / min, flurbiprofen peaks at 29.414min, crotamiton peaks between 16-17min, and the separation degree of impurity E and crotamiton is 1.21. Under this condition, the separation degree of impurity E and crotamiton is too small, and the durability test risk is relatively large, so it is not considered; under the conditions of column temperature 30℃ and flow rate 1.0ml / min, flurbiprofen peaks at 31.929min, crotamiton peaks between 16.038-19.66 The peaks of impurity E and crotamiton are between 6 minutes and 2.14, and the separation degree of impurity E and crotamiton is 2.14. Under the conditions of column temperature 30℃ and flow rate 1.2ml / min, flurbiprofen peaks at 27.648min, and crotamiton peaks between 13.618 and 16.812min, and the separation degree of impurity E and crotamiton is 2.09. The minimum separation degree and the main peak elution time of the above two chromatographic conditions are comprehensively investigated, and the chromatographic conditions of column temperature 30℃ and flow rate 1.2ml / min are temporarily optimized, such as Figure 6 As shown, the gradient is adjusted to effectively separate the peak at 15.445 min from the adjacent peaks in the test solution under sample detection.

[0107] Example 4

[0108] Method 4 for detecting related substances in flurbiprofen gel patch:

[0109] (1) Solution preparation:

[0110] Solvent (diluent): methanol

[0111] Impurity mother liquor: weigh 2.5 mg of each impurity into a 25 ml volumetric flask, dissolve and dilute to the scale with methanol (the sample weight of impurity A is 2.566 mg, the sample weight of impurity B is 2.644 mg, the sample weight of impurity C is 2.443 mg, the sample weight of impurity D is 2.675 mg, and the sample weight of impurity E is 2.537 mg).

[0112] Test spiked solution: scrape 3.0033 g of the test sample paste, add 20 ml of methanol, place in a beaker, homogenize at 8000 rpm for 5 min, seal and sonicate for 15 min, add 100 μl, 40 μl, 40 μl, 40 μl, 40 μl of impurity mother liquor of impurities A, B, C, D, and E at a time, mix well, centrifuge at 8000 rpm for 10 min, and take the supernatant.

[0113] Blank auxiliary material solution: scrape 3.0164g of blank auxiliary paste, add 20ml methanol, place in a beaker, homogenize at 8000rpm for 5min, seal and sonicate for 15min, mix well and centrifuge at 8000rpm for 10min, and take the supernatant.

[0114] (2) Chromatographic conditions

[0115] Instrument: Agilent 1260; Detector: UV

[0116] Mobile phase A: water-glacial acetic acid (60:5) (mix 1800 ml of water with 150 ml of glacial acetic acid and obtain by ultrasonication);

[0117] Mobile phase B: acetonitrile;

[0118] Flow rate: 1.2 ml / min;

[0119] Column temperature: 30°C;

[0120] Detection wavelength: 254nm;

[0121] Injection volume: 20 μl;

[0122] Diluent: Methanol

[0123] The elution procedure is as follows:

[0124]

[0125] (3) Determination: Accurately measure the blank solvent (diluent), the test sample spiked solution and the blank excipient solution and inject them into the liquid chromatograph respectively, and record the chromatogram. Typical spectra are shown in Figure 7 .

[0126] (4) Results: See Figure 7 As shown, the separation of the test spiked solutions meets the requirements, and the peak shape of impurity D needs to be further optimized, so the chromatographic conditions are adjusted.

[0127] Example 5

[0128] Method 5 for the detection of related substances in flurbiprofen gel patch:

[0129] (1) Solution preparation: The blank solvent (diluent), the test sample spiked solution and the blank excipient solution are the same as those in Example 4.

[0130] (2) Chromatographic conditions:

[0131] Instrument: Agilent 1260; Detector: UV

[0132] Mobile phase A: water-glacial acetic acid (60:5) (mix 1800 ml of water with 150 ml of glacial acetic acid and obtain by ultrasonication);

[0133] Mobile phase B: acetonitrile;

[0134] Flow rate: 1.2 ml / min;

[0135] Column temperature: 30°C;

[0136] Detection wavelength: 254nm;

[0137] Injection volume: 20 μl;

[0138] Diluent: methanol;

[0139] The elution procedure is as follows:

[0140]

[0141] (3) Determination: Take the above solutions respectively and inject them into the liquid chromatograph, and record the chromatogram. The typical spectrum is shown in Figure 7-Figure 8 .

[0142] (4) Results: See Figure 8 As shown in the graph, it can be seen that under the gradient conditions, the separation of the test + standard solution meets the requirements, and the separation of each known impurity meets the requirements. An impurity at 28.680min appeared in the test + standard solution, which was determined to be an esterification reaction between the carboxyl group of flurbiprofen and glycerol, named impurity F, and the system suitability solution was re-prepared. Results are shown in Fig. 9 As shown, under the chromatographic conditions, the system suitability separation is good, so it is determined that the chromatographic conditions are feasible.

[0143] Example 6

[0144] Method 6 for investigating diluents of related substances in flurbiprofen gel patch:

[0145] The diluent of reference raw material drug manufacturer standard, Chinese Pharmacopoeia standard, EP standard and USP standard is water-acetonitrile (55:45), 6.1725g of flurbiprofen gel patch is scraped and placed in a 50ml beaker, 20ml of diluent (water-acetonitrile 55:45) is added and homogenized with a homogenizer at 6000r / min for 2min to obtain a milky white paste sample that cannot be injected. According to the solubility of flurbiprofen, methanol is selected as the diluent for this product.

[0146] Example 7

[0147] Extraction investigation method 7 of related substances in flurbiprofen gel patch:

[0148] (1) Solution preparation:

[0149] Diluent: Methanol

[0150] Test solution: scrape 3 g of the test paste (containing about 10 mg of flurbiprofen), accurately weigh, put into a beaker, add 20 ml of methanol, and homogenize with a homogenizer at 8000 rpm for 5 min, 10 min, and 15 min, respectively. After homogenizing for 10 minutes, seal the beaker and ultrasonicate for 45 min, 60 min, and 75 min, respectively. Take an appropriate amount of diluent, centrifuge (8000 rpm, 10 min), and take the supernatant as the test solution.

[0151] (2) Chromatographic conditions: same as in Example 5.

[0152] (3) Determination

[0153] Accurately measure the diluent and the test solution, inject them into the liquid chromatograph respectively, and record the chromatogram. The data is shown in Table 2 below:

[0154] Table 2 Method development for related substances - investigation of sample extraction

[0155] Ultrasound time Flurbiprofen peak area 1 Flurbiprofen peak area 2 Homogenize for 5 minutes and ultrasonicate for 60 minutes 34318.800 33702.182 Homogenize for 10 minutes and ultrasonicate for 60 minutes 36631.690 35433.993 Homogenize for 15 minutes and ultrasonicate for 60 minutes 36448.609 36180.437 Homogenize for 10 minutes and ultrasonicate for 45 minutes 35367.381 36056.373 Homogenize for 10 minutes and ultrasonicate for 75 minutes 35159.580 34531.150

[0156] (4) Results: There was no significant difference in the extraction of flurbiprofen from the test sample under different homogenization times and ultrasonic times. Finally, homogenization for 10 minutes and ultrasonication for 60 minutes were selected.

[0157] Example 8

[0158] Method 8 for investigating the specificity of related substances in flurbiprofen gel patch:

[0159] (1) Solution preparation:

[0160] Diluent: Methanol

[0161] System suitability solution: the same as the system suitability solution in Example 5 except that impurity F was added.

[0162] Impurity A positioning solution: Take about 1.25 mg of impurity A reference substance, accurately weigh it, place it in a 20 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, accurately measure 2 ml, place it in a 10 ml volumetric flask, add methanol to dilute to the scale, shake well, and obtain.

[0163] Impurity B localization solution: Take about 1 mg of impurity B reference substance, place it in a 100 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0164] Impurity C positioning solution: Take about 1 mg of impurity C reference substance, place it in a 100 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0165] Impurity D localization solution: Take about 1.25 mg of impurity D reference substance, accurately weigh it, place it in a 20 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, accurately measure 2 ml, place it in a 10 ml volumetric flask, add methanol to dilute to the scale, shake well, and obtain.

[0166] Impurity E localization solution: Take about 1.25 mg of the impurity E reference substance, accurately weigh it, place it in a 20 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, accurately measure 2 ml, place it in a 10 ml volumetric flask, add methanol to dilute to the scale, shake well, and obtain.

[0167] Impurity F localization solution: Take about 2.5 mg of impurity F reference substance, accurately weigh it, place it in a 20 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0168] Flurbiprofen localizing solution: Take about 2.5 mg of flurbiprofen working reference substance, accurately weigh it, put it in a 100 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0169] Blank auxiliary solution: Take 3g of blank auxiliary material, weigh it accurately, put it in a beaker and add 20ml of methanol, homogenize it at 8000rpm for 5min, seal it and ultrasonicate it for 15min, add 100μl of impurity A mother solution and 40μl of impurity B mother solution in turn, mix well, centrifuge it at 8000rpm for 10min, and take the supernatant.

[0170] Test solution: weigh 3 g of the paste of this product, put it in a beaker, add 20 ml of methanol, homogenize at 8000 rpm for 5 min, seal and ultrasonicate for 15 min, add 100 μl of impurity A mother solution and 40 μl of impurity B mother solution in sequence, mix well, centrifuge at 8000 rpm for 10 min, and take the supernatant.

[0171] Unbroken blank solution: diluent.

[0172] Undamaged test solution: weigh 3 g of the product paste, put it in a beaker, add 20 ml of methanol, homogenize at 8000 rpm for 5 min, seal and ultrasonicate for 15 min, add 100 μl of impurity A mother solution and 40 μl of impurity B mother solution in sequence, mix well, centrifuge at 8000 rpm for 10 min, and take the supernatant.

[0173] Undamaged raw material solution: Take 10 mg of flurbiprofen raw material into a 20 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0174] Undamaged blank auxiliary solution: Take 3g of blank auxiliary material, accurately weigh it, put it in a beaker, and prepare it in the same way as the undamaged test solution.

[0175] Acid-destroyed test solution: Take 3g of the product paste, accurately weigh it, put it in a beaker, add 1ml of 1mol / L hydrochloric acid solution, bathe at 60℃ for 2 hours, cool to room temperature, add an appropriate amount of 1mol / L sodium hydroxide solution to neutralize it, add 18ml of methanol, homogenize with a homogenizer at 8000rpm for 10 minutes, seal the beaker and ultrasonicate for 60 minutes, filter and take the filtrate to obtain the product.

[0176] Acid-destroyed raw material solution: Take 10 mg of flurbiprofen raw material, weigh accurately, put it in a 20 ml stoppered test tube, add 1 ml of 1 mol / L hydrochloric acid solution, bathe in 60°C water for 2 hours, cool to room temperature, add an appropriate amount of 1 mol / L sodium hydroxide solution to neutralize, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0177] Acid-destroyed blank auxiliary solution: Take 3g of blank auxiliary material, accurately weigh it, put it in a beaker, and prepare it in the same way as the acid-destroyed test sample solution.

[0178] Alkali-destroyed test solution: Take 3g of the product paste, accurately weigh it, put it in a beaker, add 1ml of 1mol / L sodium hydroxide solution, place it in a 60℃ water bath for 2h, cool it to room temperature, add an appropriate amount of 1mol / L hydrochloric acid solution to neutralize it, add 18ml of methanol, homogenize it with a homogenizer at 8000rpm for 10 minutes, seal it for more than 60 minutes, filter and take the filtrate.

[0179] Alkali-destroyed raw material solution: Take 10 mg of flurbiprofen raw material, weigh accurately, put it in a 20 ml stoppered test tube, add 1 ml of 1 mol / L sodium hydroxide solution, bathe in 60°C water for 2 hours, cool to room temperature, add an appropriate amount of 1 mol / L hydrochloric acid solution to neutralize, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0180] Alkali-destroyed blank auxiliary solution: Take 3g of blank auxiliary material, accurately weigh it, put it in a beaker, and prepare it in the same way as the alkali-destroyed test solution.

[0181] Oxidatively damaged test sample solution: Take 3g of the product paste, weigh accurately, put it in a beaker, add 1ml of 30% hydrogen peroxide solution, bathe in 80℃ water for 2h, cool to room temperature, add 19ml of methanol, homogenize with a homogenizer at 8000rpm for 10min, seal and sonicate for 60min, filter and take the filtrate.

[0182] Oxidatively damaged raw material solution: Take 10 mg of flurbiprofen raw material, weigh accurately, put it in a 20 ml stoppered test tube, add 1 ml of 30% hydrogen peroxide solution, place in an 80°C water bath for 2 hours, cool to room temperature, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0183] Blank auxiliary solution for oxidative damage: Take 3g of blank auxiliary material, weigh it accurately, put it in a beaker, and prepare it in the same way as the test solution for oxidative damage.

[0184] High temperature damaged test sample (solid): Take 3g of the paste of this product, weigh it accurately, put it in a beaker, and place it in a water bath at 100℃ for 2 hours. Cool it to room temperature, add 20ml of methanol, and homogenize it with a homogenizer at 8000rpm for 10 minutes. Seal it and sonicate for 60 minutes. Centrifuge to take the supernatant or filter to take the filtrate.

[0185] Raw materials destroyed by high temperature (solid): Take 10 mg of flurbiprofen raw material, weigh accurately, put it in a 20 ml stoppered test tube, place it in a 100°C water bath for 2 hours, cool it to room temperature, add diluent to dissolve and dilute to the scale, shake well, and obtain.

[0186] High temperature destroyed blank auxiliary solution: Take 3g of blank auxiliary material, weigh it accurately, put it in a beaker, and prepare it in the same way as the high temperature destroyed test sample solution.

[0187] Light-damaged test sample (solid): Take 3g of the paste, weigh accurately, put it in a beaker, seal it, and place it under light intensity of 4500Lx±500Lx and ultraviolet 90μw / cm2 for 5 days. Take it out, add 20ml of methanol, homogenize it with a homogenizer at 8000rpm for 10 minutes, seal it and sonicate for 60 minutes, centrifuge it to take the supernatant or filter it to take the filtrate.

[0188] Light-damaged raw materials (solid): Take 10 mg of flurbiprofen raw material, accurately weigh it, put it in a 20 ml stoppered test tube, place it under light intensity of 4500Lx±500Lx and ultraviolet light of 90μw / cm2 for 5 days, take it out, add diluent to dissolve and dilute to the scale, shake well, and obtain.

[0189] Light-destroyed blank auxiliary solution: Take 3 g of blank auxiliary material, weigh it accurately, put it in a beaker, and prepare it in the same way as the high-temperature-destroyed test sample solution.

[0190] (2) Chromatographic conditions: same as in Example 5.

[0191] (3) Determination

[0192] Accurately measure the diluent, system suitability solution, each impurity location solution, flurbiprofen location solution, air auxiliary solution, test solution, undamaged test solution, acid-damaged test solution, alkali-damaged test solution, high temperature-damaged test solution, light-damaged test solution, and oxidative-damaged test solution, and inject them into the liquid chromatograph respectively, and record the chromatogram. The data are shown in Tables 3 and 4 below:

[0193] Table 3 Results of impurity location investigation

[0194] name Retention time (min) Impurity A 33.134 Impurity B 31.846 Impurity C 18.094 Impurity D 38.886 Impurity E 29.013 Impurity F 27.452 Flurbiprofen 34.852

[0195] Table 4 Test results of test solution

[0196] Components Retention time (min) Separation Unknown impurity 1 18.933 / Unknown impurity 2 26.208 11.0 Impurity F 28.170 3.3 Impurity E 29.639 2.6 Unknown impurity 3 32.362 5.6 Impurity A 33.535 2.6 Flurbiprofen 35.192 3.5 Impurity D 39.304 8.5

[0197] Table 5 Summary of degradation tests - raw materials

[0198]

[0199]

[0200] Table 6 Degradation test summary - test samples

[0201]

[0202] (4) Results: Blank solvent and blank excipients did not interfere with the determination of related substances in this product.

[0203] Under each degradation condition, the blank solvent and blank auxiliary material did not interfere with the determination of related substances of this product. Under each degradation condition, the separation between impurities and main component peaks met the requirements. The peak purity factor of the main component peak was greater than 0.980, and the mass conservation was between 90% and 110%. This method has stability indication capability.

[0204] The number and change trend of degradation products of this preparation are basically consistent with those of the reference preparation.

[0205] This method has good specificity.

[0206] Example 9

[0207] Method 9 for investigating the specificity of related substances in flurbiprofen gel patch:

[0208] (1) Solution preparation:

[0209] Diluent: methanol.

[0210] Impurity A stock solution: Take about 1.25 mg of impurity A reference substance, accurately weigh it, place it in a 20 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0211] Impurity D stock solution: Take about 1.25 mg of impurity D reference substance, accurately weigh it, place it in a 20 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0212] Impurity E stock solution: Take about 1.25 mg of the impurity E reference substance, accurately weigh it, place it in a 20 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0213] Impurity F stock solution: Take about 2.5 mg of the impurity F reference substance, accurately weigh it, place it in a 20 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0214] Reference solution: Accurately measure 1 ml each of impurity A stock solution, impurity D stock solution, impurity E stock solution, and 3 ml of impurity F stock solution, place them in a 25 ml volumetric flask, dilute to the scale with diluent, shake well, and obtain.

[0215] Test spiked solution: Take 3 g of the product paste, weigh accurately, put it in a beaker, then accurately add 1 ml each of impurity A stock solution, impurity D stock solution, impurity E stock solution, 3 ml of impurity F stock solution, add 20 ml of methanol, homogenize with a homogenizer at 8000 rpm for 10 minutes, seal and sonicate for 60 minutes, filter, and take the filtrate to obtain.

[0216] 1% self-control solution: Accurately measure 1 ml of the spiked test solution, place it in a 100 ml volumetric flask, dilute to the scale with diluent, shake well, and obtain.

[0217] (2) Chromatographic conditions: same as in Example 5.

[0218] (3) Determination

[0219] Precisely measure the diluent, reference solution, test spike solution, and 1% self-control solution, and inject them into the liquid chromatograph at different time points to record the chromatogram. The data is shown in Table 7 below:

[0220] Table 7 Results of stability test of reference solution

[0221]

[0222]

[0223] Table 8 1% self-control solution stability test results

[0224] Time (h) Flurbiprofen peak area ratio 0 384175 / 4.5 395830 1.03 9 387449 1.01 17.5 391073 1.02 45.5 391574 1.02 58.5 390761 1.02 63 387100 1.01 68 393362 1.02 72.5 390854 1.02

[0225] Table 9 Stability test results of spiked solution 1

[0226]

[0227] Table 10 Stability test results of spiked solution 2

[0228]

[0229]

[0230] (4) Results: Reference solution: The ratios of the peak areas of each component within 18.5 hours to those at 0 hours were all within the range of 0.90 to 1.10.

[0231] 1% self-control solution: The ratios of the peak areas of each component within 72.5 hours to those at 0 hours were all within the range of 0.90 to 1.10.

[0232] Spiked test solution: within 77 hours, the ratio of the main peak area to that at 0 hour is within the range of 0.98-1.02, the ratio of the peak area of ​​impurities not less than 0.1% to that at 0 hour is within the range of 0.90-1.10, for impurities less than 0.1%, the difference between the impurity peak area percentage and that at 0 hour is less than 0.02%, and no new impurities are generated.

[0233] The reference solution is basically stable at room temperature for 18.5 hours, the 1% self-control solution is basically stable at room temperature for 72.5 hours, and the test solution is basically stable at room temperature for 77 hours.

[0234] Example 10

[0235] Method 10 for investigating the specificity of related substances in flurbiprofen gel patch:

[0236] (1) Solution preparation:

[0237] Impurity mixed stock solution: Take about 1.25 mg of impurity A reference substance, about 1.25 mg of impurity D reference substance, about 1.25 mg of impurity E reference substance, and about 7 mg of impurity F reference substance, accurately weigh, place in a 50 ml volumetric flask, add methanol to dissolve and dilute to the scale, shake well, and obtain.

[0238] Blank auxiliary material solution: Take 3g of blank auxiliary material, weigh accurately, put it in a beaker, add 20ml of methanol, homogenize with a homogenizer at 8000rpm for 10 minutes, seal and ultrasonicate for 60 minutes, filter and take the filtrate to obtain.

[0239] Spiked test solution: Take 1 tablet of the product, remove the film, scrape 3g of the paste, accurately weigh, put it in a beaker, then accurately add 2ml of the impurity mixed stock solution, add 18ml of methanol, homogenize with a homogenizer at 8000rpm for 10 minutes, seal and ultrasonicate for 60 minutes, filter and take the filtrate to obtain.

[0240] 1% self-control solution: Accurately measure 1 ml of each spiked test solution, place it in a 100 ml volumetric flask, dilute to the scale with diluent, shake well, and obtain.

[0241] (2) Chromatographic conditions: same as in Example 5.

[0242] The parameters are changed as follows:

[0243] Change the flow rate, other conditions remain unchanged:

[0244] ①1.1ml / min; ②1.3ml / min

[0245] Change the column temperature, other conditions remain unchanged:

[0246] ① Column temperature 25℃; ② Column temperature 35℃

[0247] Change the proportion of mobile phase A, and keep other conditions unchanged:

[0248] ① Water-glacial acetic acid (62:3); ② Water-glacial acetic acid (58:7)

[0249] Change the chromatographic column (chromatographic column 2 is a chromatographic column of the same specification, model, and manufacturer but different type), and keep other conditions unchanged;

[0250] (3) Determination

[0251] Accurately measure 20 μL of diluent, blank auxiliary solution, test spike solution, and 1% self-control solution and inject them into the liquid chromatograph to record the chromatogram. The data is shown in Table 11 below:

[0252] Table 11 System suitability solution durability test results - retention time

[0253]

[0254]

[0255] Table 12 System suitability solution durability test results - relative retention time

[0256]

[0257] Table 13 System suitability solution durability test results - separation

[0258]

[0259] The above test results show that when the measurement conditions change slightly, the designed system suitability test can be passed.

[0260] Table 14 Durability test results of the spiked solution-1

[0261]

[0262] Table 15 Durability test results of spiked solution-2

[0263]

[0264]

[0265] Under the conditions investigated, in the system suitability solution chromatogram, the order of peak elution was impurity F, impurity E, impurity A, flurbiprofen, and impurity D, and the separation between flurbiprofen and impurity A peaks met the requirements.

[0266] The number of impurities detected in the test solution under each condition was consistent, and the change values ​​of known impurities and single unknown impurities met the requirements.

[0267] It shows that under various changing conditions, the method has good durability for different flow rates (1.1ml / min~1.3ml / min), different column temperatures (25℃~35℃), different mobile phase A ratios [water-glacial acetic acid (62:3)~(58:7)], and different numbered chromatographic columns.

Claims

1. A method for detecting related substances in flurbiprofen gel patch, It is characterized in that The following steps are involved: High performance liquid chromatography was used to quantitatively detect the related substances in flurbiprofen gel patch; HPLC conditions included: Chromatographic column: octadecylsilane bonded silica gel as filler; Mobile phase A: water-glacial acetic acid; Mobile phase B: acetonitrile; Flow rate: 1.2 ml / min; Detection wavelength: 254nm; Diluent: methanol.

2. The method for detecting related substances of the flurbiprofen gel patch according to claim 1, It is characterized in that The gradient elution method was used, and the elution procedure was as follows:

3. The method for detecting related substances of the flurbiprofen gel patch according to claim 1, It is characterized in that The related substances include impurity A: 2-(4-biphenyl) propionic acid; impurity D: 4-acetyl-2-fluorobiphenyl; impurity F: 2,3-dihydroxypropyl 2-fluoro-α-methyl (1,1'-biphenyl)-4-ethyl ester.

4. The method for detecting related substances of the flurbiprofen gel patch according to claim 3, It is characterized in that The system suitability solution and the test solution were respectively injected into the liquid chromatograph and the chromatograms were recorded. The preparation methods of the system suitability solution and the test solution were as follows: Take the reference substance of flurbiprofen gel, impurity A, impurity D, impurity E, and impurity F, add methanol to dissolve by ultrasonication, and then dilute to prepare a solution containing 0.5 mg of flurbiprofen, 2.5 μg of impurity A, 2.5 μg of impurity D, 2.5 μg of impurity E, and 15 μg of impurity F per 1 ml; As a system suitability solution; Take 3 g of the sample to be tested, weigh it accurately, put it in a beaker, add it to methanol, use a homogenizer to homogenize at 8000 rpm for 10 minutes, seal it and ultrasonicate it for 60 minutes, take an appropriate amount of solution, centrifuge it at 8000 rpm for 10 minutes, take the supernatant, filter it, and take the filtrate as the test solution.

5. The method for detecting related substances of the flurbiprofen gel patch according to claim 1, It is characterized in that Dilute the test solution 100 times with diluent to prepare a 1% self-control solution.

6. The method for detecting related substances of the flurbiprofen gel patch according to claim 1, It is characterized in that The mobile phase A is prepared by mixing water and glacial acetic acid in a volume ratio of 62:3 to 58:7, and performing ultrasonic treatment.

7. The method for detecting related substances of the flurbiprofen gel patch according to claim 1, It is characterized in that Record the chromatogram, measure using the self-control method, and calculate the content of individual impurities and total impurities.

8. The method for detecting related substances of the flurbiprofen gel patch according to claim 1, It is characterized in that The calculation method for individual impurities and total impurities is: Single impurity % = single impurity peak area / control peak area * 1%; Total impurities % = sum of impurity peak areas / control peak area*1%.

9. The method for detecting related substances of the flurbiprofen gel patch according to claim 1, It is characterized in that The injection volume was 20 μl.

10. The method for detecting related substances of the flurbiprofen gel patch according to claim 1, It is characterized in that The column temperature was 30°C.